Font Size : Increase font size Increase font size Decrease font size
The Online Health Journal Blog

«     »

One of the more aggressive and destructive forms of cancer is neuroendocrine carcinoma of colon. The worst part of this disease is that more often than not it is detected late into the advanced stages at which time it is more difficult to make treatments.

As the side effects of neuroendocrine colon cancer become visible only in the most advanced stages the rate of survival of the patient drops drastically Existing tumours are always malignant, and mostly detected with distant metastases. Surveys show the reports have revealed that most of the cases of neuroendocrine cancer end in death.

Though the possibilities of neuroendocrine carcinoma in colon are very rare, if unfortunately one is affected by this disease, the health of the patient appears even worse than those who are suffering from adenocarcinoma.

Research reveals that the end results of this form of cancer stay the same with age, sex or tumour location. However, neuroendocrine colon carcinoma will depend heavily on the tumour’s stage. Standard cases have revealed that people in stage 1 and 2 of cancer usually do not suffer from neuroendocrine colon cancer. On the other hand, in several cases, if the tumour is in stage 3 or 4, it is a laborious and hard task the neuroendocrine colon carcinoma.

Unfortunately, medical science has few techniques to deal with this particular cancer. Among the more popular methods that doctors might use is immunohistochemical staining methods. This method assists doctors with coping with the seriousness of neuroendocrine colon cancer and assists doctors in deciding on the suitable medication and a way to treat it. Immunohistochemical staining methods is specifically used for neuroendocrine markers. This involves staining of the tumour with the antibody A-80 which will help in the identification of the quantum of neuroendocrine differentiation and the extent of damage on the patient’s health.

Neuroendocrine colon carcinoma is difficult to treat and a case study in which several patients suffered from colon carcinoma was examined, it was noted that the average survival rate related to this disease was approximately seven months. In the later stages these rates drop to less than five months. The great majority of these cases were initially detected as carcinoids but they later developed in to neuroendocrine colon carcinoma. Neuroendocrine colon cancer has a bad prognosis and surgery may not be a perfect or even viable treatment so surgery may not provide a satisfactory cure. Therefore it becomes necessary to make note of carcinoma as soon as possible and provide proper medication for it.

Caltrate Colon Health is important and for more information on Dukes C Colon Carcinoma.

Post a Comment